Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Kyowa Hakko discloses UCF76-B

April 5, 1996

Regeneron investigates Tie-2 ligand

April 5, 1996

New angiogenesis inhibitors from ADIR

April 5, 1996

PD-145709: New tyrosine kinase inhibitor from Warner-Lambert

April 5, 1996

SU-101 designated orphan drug

April 5, 1996

Merck & Co. reports farnesyl transferase inhibitors

April 5, 1996

Protein kinase C modulators in the pipeline at Procyon

April 5, 1996

Antineoplastic fusion proteins from Bristol-Myers Squibb

April 5, 1996

BMS reports mutant BR96 antibodies

April 5, 1996

PPI-149 selected for development

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 12, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 12, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.